197 related articles for article (PubMed ID: 9274666)
1. Gemcitabine.
Prendiville J; O'Brien M
Br J Hosp Med; 1997 Apr 16-May 6; 57(8):405-9. PubMed ID: 9274666
[TBL] [Abstract][Full Text] [Related]
2. Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer.
Copley-Merriman C; Corral J; King K; Whiteside R; Voi M; Dorr FA; McDonald RC
Lung Cancer; 1996 Feb; 14(1):45-61. PubMed ID: 8696720
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine--a new agent in the treatment of non-small cell lung cancer. A commentary.
Carmichael J
Lung Cancer; 1999 Aug; 25(2):73-5. PubMed ID: 10470840
[No Abstract] [Full Text] [Related]
4. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
5. [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
Yokoyama A
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1294-300. PubMed ID: 10945029
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
7. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
8. Role of gemcitabine in cancer therapy.
Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
[TBL] [Abstract][Full Text] [Related]
9. Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.
Edelman MJ
Oncologist; 1999; 4(3):252-5. PubMed ID: 10394592
[No Abstract] [Full Text] [Related]
10. Gemcitabine in non-small cell lung cancer.
Crinò L; Cappuzzo F
Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
[TBL] [Abstract][Full Text] [Related]
11. Review of the pharmacoeconomic research on gemcitabine in the treatment of advanced non-small cell lung cancer.
Minshall ME; Liepa AM
Am J Manag Care; 1998 Nov; 4(11):1591-602. PubMed ID: 10338905
[TBL] [Abstract][Full Text] [Related]
12. Lung Cancer Experts' Symposium. Proceedings. Stresa, Italy, October 1997.
Semin Oncol; 1998 Aug; 25(4 Suppl 9):1-88. PubMed ID: 9728577
[No Abstract] [Full Text] [Related]
13. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
[No Abstract] [Full Text] [Related]
14. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer.
Noble S; Goa KL
Drugs; 1997 Sep; 54(3):447-72. PubMed ID: 9279506
[TBL] [Abstract][Full Text] [Related]
16. Healthcare outcomes: gemcitabine cost-effectiveness in the treatment of non-small cell lung cancer.
Szczepura A
Lung Cancer; 2002 Nov; 38 Suppl 2():S21-8. PubMed ID: 12431825
[TBL] [Abstract][Full Text] [Related]
17. Decreased myelotoxicity of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) with cisplatin infusion on day 15.
Cortesi E; Ramponi S; Corona M; Moscetti L; Grifalchi F; Oliva A; Lembo A; Gasperoni S; Padovani A
Lung Cancer; 2001; 31(2-3):271-6. PubMed ID: 11165407
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer.
Koch P; Johnson N; van Schaik J; Andersen S; Blatter J; Bosanquet N; Copley-Merriman K; Drings P
Anticancer Drugs; 1995 Dec; 6 Suppl 6():49-54. PubMed ID: 8718425
[TBL] [Abstract][Full Text] [Related]
19. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
20. [Maintenance chemotherapy in advanced NSCLC].
Krazkowski M
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
